 |
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
|
Issue: March 2026
Volume 11 | Issue 3
Review Result and Publication of Paper within : 2-3 days
Click Here For more DetailsFor Authors
Forms / Download
Published Issue Details
Editorial Board
Other IMP Links
Facts & Figure
Impact Factor : 8.14
Issue per Year : 12
Volume Published : 11
Issue Published : 118
Article Submitted : 21578
Article Published : 8531
Total Authors : 22438
Total Reviewer : 805
Total Countries : 159
Indexing Partner
Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
|
Published Paper Details
|
|
| Paper Title: | Review on: IMMUNO ONCOLOGY AGENTS FOR CANCER TREATEMENT |
| Authors Name: | Tushar M. Phalke , Priyanka D. Pote , Apuva N. Wabale , Rutuja Z. Maske , Shilpa S. Biradar |
| Download E-Certificate: | Download |
| Author Reg. ID: |
IJRTI_187352
|
| Published Paper Id: | IJRTI2306122 |
| Published In: | Volume 8 Issue 6, June-2023 |
| DOI: | |
| Abstract: | Immunotherapy is a type of cancer treatment that aims to enhance the body's immune system to detect and destroy cancer cells. It can be used alone or in combination with other treatments like chemotherapy and radiation therapy. Immunotherapy works by using substances produced by the body or created in a laboratory to stimulate the immune response against cancer. A model called the cancer immunity cycle summarises the research on each phase of a productive anti-cancer immune response. The stages involved in an effective anti-tumor immune response for tumour elimination are described by the cancer immunity cycle. The cycle starts when the immune system recognises cancer antigens. Dendritic cells (DCs), one kind of antigen-presenting cell (APC), phagocytose dying cells. These cells have the ability to seize antigens and transfer them to T lymphocytes, which can then identify and eliminate cancer cells. On the other side, cancer cells are able to evade detection by lowering T cell activation or secreting checkpoint chemicals that prevent T cell function. It is crucial to look beyond the tumour microenvironment (TME) in order to understand cancer immunology properly.It is essential to have a peripheral immune system. |
| Keywords: | Immune, surgery, oncology, vaccines, oncolytic, neoantigens,antibodies |
| Cite Article: | "Review on: IMMUNO ONCOLOGY AGENTS FOR CANCER TREATEMENT", International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2455-2631, Vol.8, Issue 6, page no.803 - 808, June-2023, Available :http://www.ijrti.org/papers/IJRTI2306122.pdf |
| Downloads: | 000205336 |
| ISSN: |
2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016 An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator |
| Publication Details: |
Published Paper ID: IJRTI2306122
Registration ID:187352
Published In: Volume 8 Issue 6, June-2023
DOI (Digital Object Identifier):
Page No: 803 - 808 Country: Pune, Maharastra, India Research Area: Pharmacy Publisher : IJ Publication Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2306122 Published Paper PDF: https://www.ijrti.org/papers/IJRTI2306122 |
| Share Article: | |
|
Click Here to Download This Article |
|
| Article Preview | |
|
|
|
Major Indexing from www.ijrti.org
| Google Scholar | ResearcherID Thomson Reuters | Mendeley : reference manager | Academia.edu |
| arXiv.org : cornell university library | Research Gate | CiteSeerX | DOAJ : Directory of Open Access Journals |
| DRJI | Index Copernicus International | Scribd | DocStoc |
ISSN Details
 |
 |
|
ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED,
Journal Starting Year (ESTD) : 2016
DOI (A digital object identifier)
| Providing A digital object identifier by DOI.ONE How to Get DOI? |
Conference
Open Access License Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Important Details
Join RMS/Earn 300
WhatsApp
Click Here
Click Here
Indexing Partner |
|||
| Copyright © 2026 - All Rights Reserved - IJRTI | |||